TW200509885A - Therapeutic agent - Google Patents
Therapeutic agentInfo
- Publication number
- TW200509885A TW200509885A TW093114148A TW93114148A TW200509885A TW 200509885 A TW200509885 A TW 200509885A TW 093114148 A TW093114148 A TW 093114148A TW 93114148 A TW93114148 A TW 93114148A TW 200509885 A TW200509885 A TW 200509885A
- Authority
- TW
- Taiwan
- Prior art keywords
- insulin
- therapeutic agent
- agent
- preventer
- enhancer
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 230000002608 insulinlike Effects 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 210000001789 adipocyte Anatomy 0.000 abstract 1
- 230000008727 cellular glucose uptake Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003140811 | 2003-05-19 | ||
| JP2003351943 | 2003-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200509885A true TW200509885A (en) | 2005-03-16 |
Family
ID=33455512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093114148A TW200509885A (en) | 2003-05-19 | 2004-05-19 | Therapeutic agent |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20070060641A1 (zh) |
| EP (1) | EP1627632A4 (zh) |
| JP (1) | JPWO2004100936A1 (zh) |
| KR (1) | KR20060003096A (zh) |
| CN (2) | CN101310716A (zh) |
| TW (1) | TW200509885A (zh) |
| WO (1) | WO2004100936A1 (zh) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0199432B1 (en) * | 1985-03-04 | 1991-05-29 | Oread Laboratories, Inc. | Assaying method for primary amines using aromatic dialdehydes |
| WO1994022806A1 (en) * | 1993-03-30 | 1994-10-13 | Kyowa Hakko Kogyo Co., Ltd. | Physiologicaly active substance res-1149-1 and derivative thereof |
| FR2709126B1 (fr) * | 1993-08-18 | 1995-09-29 | Adir | Nouveaux dérivés de naphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| JPH07145398A (ja) * | 1993-11-24 | 1995-06-06 | Lotte Co Ltd | ミント系香料の香味改善方法及びミント系香料組成物 |
| US5948460A (en) * | 1998-07-27 | 1999-09-07 | Takasago International Corporation | Flavored product additive and method for using same |
| JP4745560B2 (ja) * | 2001-09-04 | 2011-08-10 | 雅之 吉川 | 抗潰瘍剤 |
| WO2004028548A2 (en) * | 2002-09-26 | 2004-04-08 | Carbomer, Inc. | Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents |
| WO2004112819A1 (en) * | 2003-06-13 | 2004-12-29 | Gelstat Corporation | Compositions and methods of treatment comprising plant extracts |
-
2004
- 2004-05-18 US US10/557,268 patent/US20070060641A1/en not_active Abandoned
- 2004-05-18 CN CNA2008101273689A patent/CN101310716A/zh active Pending
- 2004-05-18 KR KR1020057021652A patent/KR20060003096A/ko not_active Application Discontinuation
- 2004-05-18 JP JP2005506290A patent/JPWO2004100936A1/ja active Pending
- 2004-05-18 CN CNB2004800137795A patent/CN100415218C/zh not_active Expired - Fee Related
- 2004-05-18 EP EP04733687A patent/EP1627632A4/en not_active Withdrawn
- 2004-05-18 WO PCT/JP2004/007041 patent/WO2004100936A1/ja active Application Filing
- 2004-05-19 TW TW093114148A patent/TW200509885A/zh unknown
-
2008
- 2008-11-03 US US12/263,809 patent/US20090076136A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060003096A (ko) | 2006-01-09 |
| CN1791392A (zh) | 2006-06-21 |
| EP1627632A4 (en) | 2009-01-07 |
| US20090076136A1 (en) | 2009-03-19 |
| CN101310716A (zh) | 2008-11-26 |
| JPWO2004100936A1 (ja) | 2006-07-13 |
| WO2004100936A1 (ja) | 2004-11-25 |
| CN100415218C (zh) | 2008-09-03 |
| EP1627632A1 (en) | 2006-02-22 |
| US20070060641A1 (en) | 2007-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200509886A (en) | Therapeutic agent | |
| MXPA05012061A (es) | Preparacion y uso de derivados alquilarilo para el tratamiento de la obesidad. | |
| ZA200703002B (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
| MXPA05010712A (es) | Derivados de quinolin-2-ona para el tratamiento de enfermedades de las vias respiratorias. | |
| WO2008040548A3 (en) | Treatment for non-alcoholic-steatohepatitis | |
| MX2007003013A (es) | Amidas biciclicas como inhibidores de cinasa. | |
| GB0222495D0 (en) | Compounds | |
| TW200637839A (en) | 1-thio-d-glucitol derivatives | |
| WO2004071448A3 (en) | Substituted azole derivatives as inhibitors of protein tyrosine phosphatases | |
| TNSN06030A1 (en) | Substituted thiazole-benzoisothiazole dioxide derivavites, method for the production thereof and use of the same | |
| TW200616985A (en) | Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use | |
| WO2008013987A3 (en) | N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones | |
| PL1751093T3 (pl) | Podstawione pochodne kwasu cykloheksylooctowego | |
| WO2007009724A3 (en) | Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments | |
| UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| HK1079526A1 (en) | A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin | |
| MXPA05000765A (es) | Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos. | |
| PL1745010T3 (pl) | Podstawione pochodne cykloheksylo-1,4-diaminy | |
| TW200510352A (en) | Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals | |
| AU2003260436A1 (en) | Pyrimidine compounds | |
| TW200509885A (en) | Therapeutic agent | |
| MY153733A (en) | Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same | |
| EA200701868A1 (ru) | Производные аминобутановой кислоты, ингибирующие cpt | |
| WO2006138589A3 (en) | Opioid receptor ligands |